Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
50% Dextrose Injection 0.5 g/mL, Fliptop Single Dose Vial 50 mL, Each
Manufacturer: Hospira

50% Dextrose Injection 0.5 g/mL, Fliptop Single Dose Vial 50 mL, Each

$8.44
Item Code: 000622
Mfg Part #: 00409-6648-02
This product is only available to licensed healthcare professionals.
Select your shipping method. This is helpful to expedite a portion of your order.
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
  Usually ships within 24 hours.

50% Dextrose Injection, USP is a sterile, nonpyrogenic, hypertonic solution of dextrose in water for intravenous (IV) administration. This concentrated dextrose injection is primarily indicated for the treatment of insulin hypoglycemia and as a carbohydrate calorie source in patients with restricted or inadequate oral intake.

 

Key Benefits:

  • Rapid Blood Glucose Restoration: Quickly restores blood glucose levels in cases of hypoglycemia, especially useful in emergencies.
  • Carbohydrate Caloric Support: Provides calories for patients with limited ability to consume food or nutrients orally.
  • Single-Dose Vials: Packaged in single-dose syringes and vials for safe, controlled administration.

 

Dosage and Administration:

For Intravenous Use Only with careful administration based on need:

  • Hypoglycemia Treatment: A typical dose is 10-25 grams of dextrose (20-50 mL of 50% dextrose solution) administered intravenously.
  • Parenteral Nutrition: For central venous administration, the solution must be diluted appropriately, and dosage should be customized to patient-specific caloric needs.

 

Why Choose 50% Dextrose Injection?

  • Essential for Hypoglycemic Events: Fast-acting solution to counter insulin-induced hypoglycemia.
  • Flexible Caloric Supplement: Effective source of carbohydrate calories when oral intake is compromised.
  • Convenient Packaging: Available in various forms including prefilled syringes for immediate, precise dosing.

 

Warnings:

  • Hyperosmolar Solution: Administration too rapidly may lead to hyperosmolar syndrome; monitor patients for confusion or mental changes.
  • Peripheral Vein Caution: Should be administered slowly through a large vein to minimize venous irritation.
  • Not for Subcutaneous or Intramuscular Use: Avoid non-IV administration to prevent tissue damage.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

Products specifications
Medical License Required Yes
Class Rx
Product Name Injection
Generic Name Dextrose
Route of Administration Intravenous (IV)
Strength 50%
Volume 50 mL
Container Fliptop Single Dose Vial
Feature Preservative-Free
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Hypoglycemia
Unit of Measure Each

50% Dextrose Injection, USP is a sterile, nonpyrogenic, hypertonic solution of dextrose in water for intravenous (IV) administration. This concentrated dextrose injection is primarily indicated for the treatment of insulin hypoglycemia and as a carbohydrate calorie source in patients with restricted or inadequate oral intake.

 

Key Benefits:

  • Rapid Blood Glucose Restoration: Quickly restores blood glucose levels in cases of hypoglycemia, especially useful in emergencies.
  • Carbohydrate Caloric Support: Provides calories for patients with limited ability to consume food or nutrients orally.
  • Single-Dose Vials: Packaged in single-dose syringes and vials for safe, controlled administration.

 

Dosage and Administration:

For Intravenous Use Only with careful administration based on need:

  • Hypoglycemia Treatment: A typical dose is 10-25 grams of dextrose (20-50 mL of 50% dextrose solution) administered intravenously.
  • Parenteral Nutrition: For central venous administration, the solution must be diluted appropriately, and dosage should be customized to patient-specific caloric needs.

 

Why Choose 50% Dextrose Injection?

  • Essential for Hypoglycemic Events: Fast-acting solution to counter insulin-induced hypoglycemia.
  • Flexible Caloric Supplement: Effective source of carbohydrate calories when oral intake is compromised.
  • Convenient Packaging: Available in various forms including prefilled syringes for immediate, precise dosing.

 

Warnings:

  • Hyperosmolar Solution: Administration too rapidly may lead to hyperosmolar syndrome; monitor patients for confusion or mental changes.
  • Peripheral Vein Caution: Should be administered slowly through a large vein to minimize venous irritation.
  • Not for Subcutaneous or Intramuscular Use: Avoid non-IV administration to prevent tissue damage.

 

Disclaimer:

This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.

Products specifications
Medical License Required Yes
Class Rx
Product Name Injection
Generic Name Dextrose
Route of Administration Intravenous (IV)
Strength 50%
Volume 50 mL
Container Fliptop Single Dose Vial
Feature Preservative-Free
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Hypoglycemia
Unit of Measure Each

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President